Kura Oncology (KURA) Operating Income (2010 - 2026)
Kura Oncology (KURA) reported Operating Income of -$78.8 million for Q1 2026, down 21.82% year-over-year from -$100.8 million in Q1 2025, and down 21.82% on a QoQ basis from -$64.7 million in Q1 2025.
Kura Oncology (KURA) has 7 years of Operating Income data on file, last reported at -$78.8 million in Q1 2026.
- Quarterly Operating Income fell 21.82% year-over-year to -$78.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$143.5 million (down 121.77% YoY) and the FY2025 annual result came in at -$303.6 million, down 57.16% from the prior year.
- Operating Income eased to -$78.8 million in Q1 2026 per KURA's latest filing, from -$64.7 million in the prior quarter.
- Across five years, Operating Income topped out at -$64.7 million in Q1 2025 and bottomed at -$78.8 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -78.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.82 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
| Jun 30, 2012 | -4,996.00 |
| Mar 31, 2012 | -4,241.00 |
| Dec 31, 2011 | -7,976.00 |
| Sep 30, 2011 | -5,360.00 |
| Jun 30, 2011 | -5,837.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |
| Sep 30, 2010 | -4,238.00 |